Apex, NC, United States of America

Stephen V Evola


Average Co-Inventor Count = 11.7

ph-index = 5

Forward Citations = 223(Granted Patents)


Company Filing History:


Years Active: 1996-2002

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovations of Stephen V Evola

Introduction

Stephen V Evola is a notable inventor based in Apex, NC (US), recognized for his contributions to agricultural biotechnology. With a total of 8 patents, he has made significant advancements in the field of maize transformation and insect resistance.

Latest Patents

Evola's latest patents include a method of producing transgenic maize using direct transformation of commercially important genotypes. This method involves subjecting immature zygotic embryos or Type I callus to high-velocity microprojectile bombardment. The technique is capable of producing transformed maize lines of commercial importance and their hybrid combinations. Another significant patent involves synthetic DNA sequences having enhanced insecticidal activity in maize. These DNA sequences are optimized for expression in plants and encode insecticidal polypeptides, particularly proteins that exhibit insecticidal properties. The patents also provide transformation vectors that demonstrate high levels of insecticidal activity when introduced into maize.

Career Highlights

Throughout his career, Stephen V Evola has worked with prominent companies such as Novartis Finance Corporation and Ciba-Geigy Corporation. His work has focused on developing innovative solutions to improve crop resilience and productivity.

Collaborations

Evola has collaborated with notable professionals in his field, including Michael G Koziel and Gregory W Warren. Their combined expertise has contributed to the advancement of agricultural biotechnology.

Conclusion

Stephen V Evola's innovative work in maize transformation and insect resistance has made a significant impact on agricultural biotechnology. His patents reflect a commitment to enhancing crop performance and sustainability.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…